참고문헌
- Ahn JM, Sung HJ, Yoon YH, et al (2013). Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. Mol Cell Proteomics.
- Akcay MN, Polat MF, Yilmaz I, Akcay G (2003). Serum paraoxonase levels in pancreatic cancer. Hepatogastroenterology, 50, 225-7.
- Akcay MN, Polat MF, Yilmaz I, Akcay G (2003). Serum paraoxonase levels in gastric cancer. Hepatogastroenterology, 50, 273-5
- Anastasiadis P, Koutlaki N, Liberis V, et al (2011). The contribution of rapid intraoperative cytology in the evaluation of endometrial cancer spread. Ann Acad Med Singapore, 40, 80-3.
- Arpaci A, Gormus U, Dalan B, Berkman S, Isbir T (2009). Investigation of PON1 192 and PON1 55 polymorphisms in Ovarian Cancer Patients in Turkish Population. In Vivo, 23, 421-4.
- Arumanayagam M, Wong FW, Rogers M, Swaminathan R (1993). Serum ceruloplasmin, plasma copper concentration and copper to ceruloplasmin ratio in cervical carcinoma. Gynecol Obstet Invest, 35, 175-8. https://doi.org/10.1159/000292694
- Bobin-Dubigeon C, Jaffre I, Joalland MP, et al (2012). Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrence. Clin Biochem, 45, 1503-5. https://doi.org/10.1016/j.clinbiochem.2012.05.021
- Camuzcuoglu H, Arioz DT, Toy H, et al (2009). Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Gynecol Oncol, 112, 481-5. https://doi.org/10.1016/j.ygyno.2008.10.031
- Canales A, Sanchez-Muniz FJ (2003). Paraoxanase, something more than an enzyme? Med Clin, 121, 537-48. https://doi.org/10.1016/S0025-7753(03)74011-1
- Delimaris I, Faviou E, Antonakos G, et al (2007). Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem, 40, 1129-34. https://doi.org/10.1016/j.clinbiochem.2007.06.007
- Eckerson HW, Romson J, Wyte C, La Du BN (1983). The human serum paraoxonase polymorphism: identification of Phenotypes by their response to salts. Am J Hum Genet, 35, 214-27.
- Elkiran ET, Mar N, Aygen B, et al (2007). Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer, 7, 48. https://doi.org/10.1186/1471-2407-7-48
- Khersonsky O, Tawfik DS (2005). Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry, 44, 6371-82. https://doi.org/10.1021/bi047440d
- Kokouva M, Koureas M, Dardiotis E, et al (2013). Relationship between the paraoxonase 1 (PON1) M55L and Q192R polymorphisms and lymphohaematopoietic cancers in a Greek agricultural population. Toxicology, 307, 12-6. https://doi.org/10.1016/j.tox.2012.07.003
- Kosaka T, Yamaguchi M, Motomura T, Mizuno K (2005). Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay. Clin Chim Acta, 359, 156-62. https://doi.org/10.1016/j.cccn.2005.03.046
- Krzystek-Korpacka M, Boehm D, Matusiewicz M, et al (2008). Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromesconnection with inflammation. Clin Biochem, 41, 804-11. https://doi.org/10.1016/j.clinbiochem.2008.03.012
- La Du BN, Piko JI, Eckerson HW, Vincent-Viry M, Siest G (1986). An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism. Ann Biol Clin, 44, 369-72.
- La Du BN, Aviram M, Billecke S, et al (1999). On the physiological role(s) of the paraoxonasese. Chem Biol Interac, 119-120, 379-88. https://doi.org/10.1016/S0009-2797(99)00049-6
- La Du BN, Billecke S, Hsu C, Haley RW, Broomfield CA (2001). Serum paraoxonase (PON1) isozymes: the quantitative analysis of isozymes affect-ing individual sensitivity to environmental chemicals. Drug Metab Dispos, 29, 566-9.
- Macharia M, Hassan MS, Blackhurst D, Erasmus RT, Matsha TE (2012). The growing importance of PON1 in cardiovascular health: a review. J Cardiovasc Med (Hagerstown), 13, 443-53. https://doi.org/10.2459/JCM.0b013e328354e3ac
- Mathur V, John PJ, Soni I, Bhatnagar P (2008). Blood levels of organochlorine pesticide residues and risk of reproductive tract cancer among women from Jaipur, India. Adv Exp Med Biol, 617, 387-94. https://doi.org/10.1007/978-0-387-69080-3_37
- Ng CJ, Shih DM, Hama SY, et al (2005). The paraoxonase gene family and atherosclerosis. Free Radic Biol Med, 38, 153-63. https://doi.org/10.1016/j.freeradbiomed.2004.09.035
- Nowak M, Wielkoszynski T, Marek B, et al (2010). Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy. Clin Exp Med, 10, 185-92. https://doi.org/10.1007/s10238-009-0084-7
- Ozyilkan O, Baltali E, Ozyilkan E, et al (1992). Ceruloplasmin level in women with breast disease. Preliminary results. Acta Oncol, 31, 843-6. https://doi.org/10.3109/02841869209089716
- Ray G, Batra S, Shukla NK, et al (2000). Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat, 59, 163-70. https://doi.org/10.1023/A:1006357330486
- Sankaranarayanan R, Ferlay J (2006). Worldwide burd of gynaecological cancer; the size of the problem. Best Pract Res Clin Obstet Gynaecol, 20, 207-25. https://doi.org/10.1016/j.bpobgyn.2005.10.007
- Sarkar M, Konar H, Raut DK (2012). Gynecological malignancies: epidemiological characteristics of the patients in a tertiary care hospital in India. Asian Pac J Cancer Prev, 13, 2997-3004. https://doi.org/10.7314/APJCP.2012.13.6.2997
- Sathiakumar N, MacLennan PA, Mandel J, Delzell E (2011). A review of epidemiologic studies of triazine herbicides and cancer. Crit Rev Toxicol, 41, 1-34.
- Senra Varela A, Lopez Saez JJ, Quintela Senra D (1997). Serum ceruloplasmin as a diagnostic marker of cancer. Cancer Lett, 121, 139-45. https://doi.org/10.1016/S0304-3835(97)00340-6
- Selvaggi SM (2003). Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis. Diagn Cytopathol, 28, 335-41. https://doi.org/10.1002/dc.10290
- Sharifi S, Ducatman BS, Wang HH, Fraser JL (1999). Peritoneal washing cytology is unnecessary in gynecologic surgery for benign diseases. Cancer, 87, 259-62. https://doi.org/10.1002/(SICI)1097-0142(19991025)87:5<259::AID-CNCR4>3.0.CO;2-O
- Shield P (2004). Peritoneal washing cytology. Cytopathology, 15, 131-41. https://doi.org/10.1111/j.1365-2303.2004.00140.x
- Stevens VL, Rodriguez C, Talbot JT, et al (2008). Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort. Prostate, 68, 1336-40. https://doi.org/10.1002/pros.20796
- Vaidya SM, Kamalakar PL (1998). Copper and ceruloplasmin levels in serum of women with breast cancer. Indian J Med Sci, 52, 184-7.
- Yildirim M, Karakilinc H, Yildiz M, et al (2013). Non-hodgkin lymphoma and pesticide exposure in Turkey. Asian Pac J Cancer Prev, 14, 3461-3. https://doi.org/10.7314/APJCP.2013.14.6.3461
- Zhou ZJ, Zheng J, Wu QE, Xie F (2007). Carboxylic esterase and its associations with long-term effects of organophosphorus pesticides. Biomed Environ Sci, 20, 284-90.
- Zuna RE, Behrens A (1996). Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. J Natl Cancer Inst, 88, 980-7. https://doi.org/10.1093/jnci/88.14.980